IRCT20201118049433N1
Completed
Phase 3
Comparison of the effect of adding a single dose of fenofibrate to phenobarbital in the treatment of prolonged neonatal jaundice with phenobarbital alone
ConditionsProlonged neonatal jaundice.
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Prolonged neonatal jaundice.
- Sponsor
- Islamic Azad University
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Infants who are full\-term (gestational age between 37 and 41 weeks)
- •All infants between the ages of 14 and 40 days
- •All infants weighing between 2500 and 4000 grams
- •Infants who are breastfed
- •All infants with total bilirubin 10 to 20 mg/dL
- •Infants who show no signs of hemolysis on a blood test
- •Infants who do not have symptoms of an infectious disease or any abnormality
Exclusion Criteria
- •Infants who are dehydrated
- •Infants who test positive for Coombs
- •Infants with indirect bilirubin more than 2 mg/d
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
Assessing the efficacy of different medications in decreasing complications of transureteral lithotripsyreteral stone.N 21IRCT20161221031505N1Tehran University of Medical Sciences400
Active, not recruiting
Phase 4
effect of dexamethasone in reducing pain after gall bladder operatioHealth Condition 1: null- Patients of laparoscopic cholecystectomy between age 18 and 65 years with no comorbiditiesCTRI/2016/10/007362Dr Surendra Singh100
Completed
Phase 2
The effect of a single dose of oral Pregabalin single oral dose of gabapentin on pain controlPain.Other specified disorders of boneIRCT201502126186N8Vice chancellor for research of Guilan University of Medical Sciences60
Not yet recruiting
Phase 3
The effect of continuous administration of two doses of sufentanil on changes in heart rate and blood pressure after laryngoscopy and tracheal intubatioIRCT20200825048515N62Esfahan University of Medical Sciences90
Active, not recruiting
Phase 1
An investigation of the efficacy of a single dose of insulin in the prevention of excessive cutaneous scarring in breast surgery patients - Insulin as anti-scarring agent - breast surgery groupScarring arising from non cancer-related bilateral breast surgeryEUCTR2010-022290-34-GBPharmecosse75